C30-NBOMe

C30-NBOMe, or 30C-NBOMe, also known as N-(3,4,5-trimethoxybenzyl)-4-chloro-2,5-dimethoxyphenethylamine or as 25C-NB345OMe, is a serotonin receptor modulator of the phenethylamine, 2C, and 25-NB (NBOMe) families.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

C30-NBOMe, or 30C-NBOMe, also known as N-(3,4,5-trimethoxybenzyl)-4-chloro-2,5-dimethoxyphenethylamine or as 25C-NB345OMe, is a serotonin receptor modulator of the phenethylamine, 2C, and 25-NB (NBOMe) families. It is an analogue of 25C-NBOMe with three methoxy groups on the benzyl ring, located at the 3, 4, and 5 positions.

The drug was encountered as a novel designer drug in Sweden in 2013. However, C30-NBOMe showed greater than or equal to 1,000-fold lower potency as a serotonin 5-HT 2A receptor agonist in vitro compared to conventional 25-NB drugs like 25I-NBOMe and 25B-NBOMe ( = 1,251 nM vs. 0.40–1.2 nM, respectively).

Its affinity for the serotonin 5-HT 2A receptor was similarly low (K i = 515 nM, versus 0.82 nM for 25C-NBOMe). The chemical identification of C30-NBOMe has been studied and described.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359027560 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.